Volcano Corp (NASDAQ:VOLC)

CAPS Rating: 2 out of 5

The Company is engages in the development, manufacture and commercialization of intravascular ultrasound and functional measurement products that are used for the diagnosis and treatment of vascular and structural heart disease.

Recs

0
Player Avatar randysfun (< 20) Submitted: 6/19/2007 7:23:28 PM : Outperform Start Price: $21.48 VOLC Score: +43.02

product is best in show probably a buyout canidate

Featured Broker Partners


Advertisement